← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2014Last known activity
Nov 19, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 5 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT05021016Overall official - principal investigatorPhase 3Nov 19, 2020
- NCT04527575Overall official - principal investigatorPhase 1/Phase 2Jul 27, 2020
- NCT04347031Reponsible party - principal investigatorPhase 2Apr 8, 2020
- NCT04347031Lead sponsorPhase 2Apr 8, 2020
- NCT04347031Overall official - principal investigatorPhase 2Apr 8, 2020
- NCT02758912Lead sponsorPhase 4Apr 1, 2016
- NCT02145923Reponsible party - principal investigatorPhase 1/Phase 2May 1, 2014
- NCT02145923Lead sponsorPhase 1/Phase 2May 1, 2014
- NCT02145923Overall official - principal investigatorPhase 1/Phase 2May 1, 2014
Details
- Last known activity
- Nov 19, 2020